Microsoft and MITRE have developed a tool that works like an automated adversarial attack library for those that lack a deep background in machine learning or artificial intelligence, providing insights on how these attacks work and an opportunity to build defenses.
WHY IT MATTERS
AI algorithms…
Source: Healthcareitnews.com and Read More
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
